Anti-Ageing Cosmeceuticals Market Set To Grow To $19bn By 2022

14 August 2018
Pharma

Visiongain’ has launched a new pharma report Anti-Ageing Cosmeceuticals 2017-2027:
Anti-wrinkle, Anti-stretch Mark, UV Absorbers, Hair, Topical, Invasive, Acne Therapy, Liposuction, Breast Augmentation, Hair Growth, Eyelid Surgery, Botox, Anti-pigmentation, Abdominoplasty, Other Services

Cosmeceuticals are the future generation of cosmetics and personal care industry as they not only improve appearance but also provide necessary nutrients and drug-like properties to the skin. The core properties of cosmeceuticals may be considered as hybrid of traditional cosmetics and medicines or drugs. Technological advancements have resulted in the launch of advanced and more value-added anti-ageing products in the market.

The lead analyst of the report commented “The growth in per capita disposable income, increasing baby boomer population and rising demand in anti-ageing products due to pollution and fluctuating climatic conditions have boosted the growth of anti-ageing cosmeceuticals market. Furthermore, advertisement and promotional activities from companies have strongly influenced the purchasing power and behaviours of consumers.”

Leading companies featured in the report include Allergan PLC, Avon Products Inc.
Beiersdorf AG, Chanel International B.V., Christian Dior SE, Johnson & Johnson, L'ORÉAL S.A., PROCTER & GAMBLE, Revlon Inc., Unilever PLC.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

Read

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

Read

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

Read

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever